Modulatory Role for Retinoid-related Orphan Receptor Alpha in Allergen-induced Lung Inflammation
Overview
Authors
Affiliations
Rationale: Nuclear receptors play a critical role in the regulation of inflammation, thus representing attractive targets for the treatment of asthma.
Objective: In this study, we assess the potential regulatory function of retinoid-related orphan receptor alpha (RORalpha) in the adaptive immune response using ovalbumin (OVA)-induced airway inflammation as a model.
Methods: Allergen-induced inflammation was compared between wild-type (WT) and staggerer (RORalpha(sg/sg)) mice, a natural mutant strain that is deficient in RORalpha expression.
Measurements And Main Results: Despite robust increases in OVA-specific IgE, RORalpha(sg/sg) mice developed significantly less pulmonary inflammation, mucous cell hyperplasia, and eosinophilia compared with similarly treated WT animals. Induction of Th2 cytokines, including interleukin (IL)-4, IL-5, and IL-13, was also significantly less in RORalpha(sg/sg) mice. Microarray analysis using lung RNA showed increased expression of many genes, previously implicated in inflammation, in OVA-treated WT mice. These include mucin Muc5b, the chloride channel calcium-activated 3 (Clca3), macrophage inflammatory protein (MIP) 1alpha and 1beta, eotaxin-2, serum amyloid A3 (Saa3), and insulin-like growth factor 1 (Igf1). These genes were induced to a greater extent in OVA-treated WT mice relative to RORalpha(sg/sg) mice.
Conclusions: Our study demonstrates that mice deficient in RORalpha exhibit an attenuated allergic inflammatory response, indicating that RORalpha plays a critical role in the development of Th2-driven allergic lung inflammation in mice, and suggests that this nuclear receptor should be further evaluated as a potential asthma target.
RAR-related orphan receptor alpha and the staggerer mice: a fine molecular story.
Rani A Front Endocrinol (Lausanne). 2024; 14:1300729.
PMID: 38766309 PMC: 11099308. DOI: 10.3389/fendo.2023.1300729.
Duraisamy S, Srinivasan A, Sundar I Tissue Barriers. 2023; 12(1):2203841.
PMID: 37079442 PMC: 10832928. DOI: 10.1080/21688370.2023.2203841.
Yu Q, Shi Y, Shu C, Ding X, Zhu S, Shen Z Evid Based Complement Alternat Med. 2021; 2021:6862073.
PMID: 34194525 PMC: 8181172. DOI: 10.1155/2021/6862073.
Nuclear Receptors in Asthma: Empowering Classical Molecules Against a Contemporary Ailment.
Tiwari D, Gupta P Front Immunol. 2021; 11:594433.
PMID: 33574813 PMC: 7870687. DOI: 10.3389/fimmu.2020.594433.
Hams E, Roberts J, Bermingham R, Hogan A, OShea D, ONeill L Front Immunol. 2020; 11:1966.
PMID: 32973801 PMC: 7482427. DOI: 10.3389/fimmu.2020.01966.